Vicente Esther, Charnaud Sarah, Bongard Emily, Villar Raquel, Burguete Asunción, Solano Beatriz, Ancizu Saioa, Pérez-Silanes Silvia, Aldana Ignacio, Vivas Livia, Monge Antonio
Unidad de Investigación y Desarrollo de Medicamentos, Centro de Investigación en Farmacobiología Aplicada (CIFA), University of Navarra, 31080 Pamplona, Spain.
Molecules. 2008 Jan 17;13(1):69-77. doi: 10.3390/molecules13010069.
The aim of this study was to identify new compounds active against Plasmodium falciparum based on our previous research carried out on 3-phenyl-quinoxaline-2-carbonitrile 1,4-di-N-oxide derivatives. Twelve compounds were synthesized and evaluated for antimalarial activity. Eight of them showed an IC(50) less than 1 microM against the 3D7 strain. Derivative 1 demonstrated high potency (IC(50)= 0.63 microM) and good selectivity (SI=10.35), thereby becoming a new lead-compound.
本研究的目的是基于我们之前对3-苯基喹喔啉-2-甲腈1,4-二氮氧化物衍生物的研究,鉴定对恶性疟原虫有活性的新化合物。合成了12种化合物并评估其抗疟活性。其中8种对3D7株的IC(50)小于1 microM。衍生物1表现出高效力(IC(50)=0.63 microM)和良好的选择性(SI=10.35),从而成为一种新的先导化合物。